SCHEMBL8109005

SCHEMBL8109005

CCCOCCCCN1CCC(=NO)CC1.CCCOCCCCN1CCC(=NO)CC1

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 1/20 0.36
HRH3 Q9Y5N1 4/20 0.35
KDM4E B2RXH2 4/20 0.34
ALDH1A1 P00352 3/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
MAPT P10636 1/20 0.34
TAAR1 Q96RJ0 1/20 0.34
ABCB1 P08183 1/20 0.33
GNAI3 P08754 1/20 0.33
GNAO1 P09471 1/20 0.33
GNAI1 P63096 1/20 0.33
S1PR5 Q9H228 1/20 0.32
RECQL P46063 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
TSHR P16473 1/20 0.32
LTA4H P09960 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6948599 1.00 CHRNA7 (0.36) CHRNA7HRH3KDM4EALDH1A1L3MBTL1
SCHEMBL6944358 0.98 HRH3 (0.35) CHRNA7HRH3ALDH1A1L3MBTL1GNAI3
SCHEMBL6943611 0.98 HRH3 (0.35) CHRNA7HRH3ALDH1A1L3MBTL1GNAI3
SCHEMBL8099737 0.98 HRH3 (0.35) CHRNA7HRH3ALDH1A1L3MBTL1GNAI3
SCHEMBL8099695 0.95 HRH3 (0.38) CHRNA7HRH3KDM4EALDH1A1MAPT
SCHEMBL6941458 0.95 HRH3 (0.38) CHRNA7HRH3KDM4EALDH1A1MAPT
SCHEMBL6942975 0.94 HRH3 (0.38) CHRNA7HRH3KDM4EALDH1A1ABCB1
SCHEMBL8113367 0.94 HRH3 (0.38) CHRNA7HRH3KDM4EALDH1A1ABCB1
SCHEMBL8108588 0.92 LTA4H (0.40) HRH3ALDH1A1GNAI3GNAO1GNAI1
SCHEMBL6943853 0.92 LTA4H (0.40) HRH3ALDH1A1GNAI3GNAO1GNAI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056744-A1 6,9-DISUBSTITUTED 2- TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES Aventis Pharmaceuticals Inc. (US) 2000-12-06 EP disclosed
WO-1999043675-A1 6,9-DISUBSTITUTED 2-[TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES AVENTIS PHARMACEUTICALS INC. (US) 1999-09-02 WO disclosed